Trials / Withdrawn
WithdrawnNCT00875875
Single Daily Dose Rifaximin for the Treatment of Travelers' Diarrhea
Single Daily Dose Rifaximin vs. Standard Thrice Daily Dosing for the 3-Day Treatment of Travelers' Diarrhea
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- The University of Texas Health Science Center, Houston · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study will compare durations of diarrhea among subjects who report to clinic for treatment and who receive either: 1. standard rifaximin therapy at a dose of 200 mg three times a day for 3 days, OR 2. a single 600 mg dose of rifaximin daily for 3 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rifaximin | Rifaximin 200 mg TID for 3 days OR Rifaximin 600 mg Daily for 3 days |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2009-06-01
- Completion
- 2009-06-01
- First posted
- 2009-04-06
- Last updated
- 2015-06-10
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT00875875. Inclusion in this directory is not an endorsement.